Cannabinoid CB1 receptor-dependent long-term depression in autaptic excitatory neurons

Journal of Neurophysiology

Volumn 102, Issue 2, 2009, Pages 1160-1171

  Kellogg, Ryan ^a   Mackie, Ken ^a,b   Straiker, Alex ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b INDIANA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 ARACHIDONOYLGLYCEROL; CANNABINOID 1 RECEPTOR; ENDOCANNABINOID; GLUTAMATE RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; IONOTROPIC RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE; PHOSPHOLIPASE C; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE;

ANIMAL CELL; ARTICLE; CELL MEMBRANE DEPOLARIZATION; CONTROLLED STUDY; ENZYME ACTIVATION; LONG TERM DEPRESSION; NERVE CELL MEMBRANE; NERVE CELL PLASTICITY; NONHUMAN; PRIORITY JOURNAL; ANALYSIS OF VARIANCE; ANIMAL; CELL CULTURE; DRUG ANTAGONISM; ELECTROSTIMULATION; EXCITATORY POSTSYNAPTIC POTENTIAL; GENETICS; HIPPOCAMPUS; METABOLISM; MOUSE; MOUSE MUTANT; NERVE CELL; PATCH CLAMP; PHYSIOLOGY; SYNAPSE; TIME;

ANALYSIS OF VARIANCE; ANIMALS; CELLS, CULTURED; ELECTRIC STIMULATION; EXCITATORY POSTSYNAPTIC POTENTIALS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HIPPOCAMPUS; LONG-TERM SYNAPTIC DEPRESSION; MAP KINASE KINASE KINASES; MICE; MICE, KNOCKOUT; NEURONS; PATCH-CLAMP TECHNIQUES; RECEPTOR, CANNABINOID, CB1; RECEPTORS, GLUTAMATE; SYNAPSES; TIME FACTORS;

EID: 68149178393     PISSN: 00223077     EISSN: 15221598     Source Type: Journal    
DOI: 10.1152/jn.00266.2009     Document Type: Article

References (59)

1. Adermark L, Talani G, Lovinger DM. Endocannabinoid-dependent plasticity at GABAergic and glutamatergic synapses in the striatum is regulated by synaptic activity. Eur J Neurosci 29: 32-41, 2009.
2. Bekkers JM, Stevens CF. Excitatory and inhibitory autaptic currents in isolated hippocampal neurons maintained in cell culture. Proc Natl Acad Sci USA 88: 7834-7838, 1991.
3. Bolshakov VY, Siegelbaum SA. Postsynaptic induction and presynaptic expression of hippocampal long-term depression. Science 264: 1148-1152, 1994.
4. Chen K, Neu A, Howard AL, Foldy C, Echegoyen J, Hilgenberg L, Smith M, Mackie K, Soltesz I. Prevention of plasticity of endocannabinoid signaling inhibits persistent limbic hyperexcitability caused by developmental seizures. J Neurosci 27: 46-58, 2007.
5. Chevaleyre V, Castillo PE. Heterosynaptic LTD of hippocampal GABAergic synapses: a novel role of endocannabinoids in regulating excitability. Neuron 38: 461-472, 2003.
6. Chevaleyre V, Takahashi KA, Castillo PE. Endocannabinoid-mediated synaptic plasticity in the CNS. Annu Rev Neurosci 29: 37-76, 2006.
7. Citri A, Malenka RC. Synaptic plasticity: multiple forms, functions, and mechanisms. Neuropsychopharmacology 33: 18-41, 2008.
8. Daigle TL, Kearn CS, Mackie K. Rapid CB1 cannabinoid receptor desensitization defines the time course of ERK1/2 MAP kinase signaling. Neuropharmacology 54: 36-44, 2008a.
9. Daigle TL, Kwok ML, Mackie K. Regulation of CB(1) cannabinoid receptor internalization by a promiscuous phosphorylation-dependent mechanism. J Neurochem 106: 70-82, 2008b.
10. Davis MI, Ronesi J, Lovinger DM. A predominant role for inhibition of the adenylate cyclase/protein kinase A pathway in ERK activation by cannabinoid receptor 1 in N1E-115 neuroblastoma cells. J Biol Chem 278: 48973-48980, 2003.
11. Debanne D, Guerineau NC, Gahwiler BH, Thompson SM. Paired-pulse facilitation and depression at unitary synapses in rat hippocampus: quantal fluctuation affects subsequent release. J Physiol 491: 163-176, 1996.
12. Derkinderen P, Valjent E, Toutant M, Corvol JC, Enslen H, Ledent C, Trzaskos J, Caboche J, Girault JA. Regulation of extracellular signal-regulated kinase by cannabinoids in hippocampus. J Neurosci 23: 2371-2382, 2003.
13. Edwards DA, Zhang L, Alger BE. Metaplastic control of the endocannabinoid system at inhibitory synapses in hippocampus. Proc Natl Acad Sci USA 105: 8142-8147, 2008.
14. Furshpan EJ, MacLeish PR, O'Lague PH, Potter DD. Chemical transmission between rat sympathetic neurons and cardiac myocytes developing in microcultures: evidence for cholinergic, adrenergic, and dual-function neurons. Proc Natl Acad Sci USA 73: 4225-4229, 1976.
15. Galve-Roperh I, Rueda D, Gomez del Pulgar T, Velasco G, Guzman M. Mechanism of extracellular signal-regulated kinase activation by the CB(1) cannabinoid receptor. Mol Pharmacol 62: 1385-1392, 2002.
16. Gaoni Y, Mechoulam R. Isolation, structure and partial synthesis of an active constituent of hashish. J Am Chem Soc 86: 1646-1647, 1964.
17. Gerdeman GL, Ronesi J, Lovinger DM. Postsynaptic endocannabinoid release is critical to long-term depression in the striatum. Nat Neurosci 5: 446-451, 2002.
18. Glass M, Felder CC. Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors augments cAMP accumulation in striatal neurons: evidence for a Gs linkage to the CB1 receptor. J Neurosci 17: 5327-5333, 1997.
19. Goda Y, Stevens CF. Long-term depression properties in a simple system. Neuron 16: 103-111, 1996.
20. Goda Y, Stevens CF. Readily releasable pool size changes associated with long term depression. Proc Natl Acad Sci USA 95: 1283-1288, 1998.
21. Harris DN, Asaad MM, Phillips MB, Goldenberg HJ, Antonaccio MJ. Inhibition of adenylate cyclase in human blood platelets by 9-substituted adenine derivatives. J Cyclic Nucleotide Res 5: 125-134, 1979.
22. Hashimotodani Y, Ohno-Shosaku T, Maejima T, Fukami K, Kano M. Pharmacological evidence for the involvement of diacylglycerol lipase in depolarization-induced endocanabinoid release. Neuropharmacology 54: 58-67, 2008.
23. Hashimotodani Y, Ohno-Shosaku T, Tsubokawa H, Ogata H, Emoto K, Maejima T, Araishi K, Shin HS, Kano M. Phospholipase Cbeta serves as a coincidence detector through its Ca(2+) dependency for triggering retrograde endocannabinoid signal. Neuron 45: 257-268, 2005.
24. Heifets BD, Chevaleyre V, Castillo PE. Interneuron activity controls endocannabinoid-mediated presynaptic plasticity through calcineurin. Proc Natl Acad Sci USA 105: 10250-10255, 2008.
25. Hepler JR, Gilman AG. G proteins. Trends Biochem Sci 17: 383-387, 1992.
26. Hirasawa M, Schwab Y, Natah S, Hillard CJ, Mackie K, Sharkey KA, Pittman QJ. Dendritically released transmitters cooperate via autocrine and retrograde actions to inhibit afferent excitation in rat brain. J Physiol 559: 611-624, 2004.
27. Hourani SM, Boon K, Fooks HM, Prentice DJ. Role of cyclic nucleotides in vasodilations of the rat thoracic aorta induced by adenosine analogues. Br J Pharmacol 133: 833-840, 2001.
28. Howlett AC, Barth F, Bonner TI, Cabral G, Casellas P, Devane WA, Felder CC, Herkenham M, Mackie K, Martin BR, Mechoulam R, Pertwee RG. International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol Rev 54: 161-202, 2002.
29. Howlett AC, Qualy JM, Khachatrian LL. Involvement of Gi in the inhibition of adenylate cyclase by cannabimimetic drugs. Mol Pharmacol 29: 307-313, 1986.
30. Isokawa M, Alger BE. The ryanodine receptor regulates endogenous cannabinoid mobilization in the hippocampus. J Neurophysiol 95: 3001-3011, 2006.
31. Kano M, Ohno-Shosaku T, Hashimotodani Y, Uchigashima M, Watanabe M. Endocannabinoid-mediated control of synaptic transmission. Physiol Rev 89: 309-380, 2009.
32. Karanian DA, Brown QB, Makriyannis A, Bahr BA. Blocking cannabinoid activation of FAK and ERK1/2 compromises synaptic integrity in hippocampus. Eur J Pharmacol 508: 47-56, 2005.
33. 2+ currents by endocannabinoids released via postsynaptic mGluR activation at a calyx synapse. J Neurosci 24: 5955-5965, 2004.
34. Lauckner JE, Hille B, Mackie K. The cannabinoid agonist WIN55,212-2 increases intracellular calcium via CB1 receptor coupling to Gq/11 G proteins. Proc Natl Acad Sci USA 102: 19144-19149, 2005.
35. Levison SW, McCarthy KD. Characterization and partial purification of AIM: a plasma protein that induces rat cerebral type 2 astroglia from bipotential glial progenitors. J Neurochem 57: 782-794, 1991.
36. Mailman RB. GPCR functional selectivity has therapeutic impact. Trends Pharmacol Sci 28: 390-396, 2007.
37. Malenka RC, Bear MF. LTP and LTD: an embarrassment of riches. Neuron 44: 5-21, 2004.
38. Mennerick S, Zorumski CF. Paired-pulse modulation of fast excitatory synaptic currents in microcultures of rat hippocampal neurons. J Physiol 488: 85-101, 1995.
39. Nosyreva ED, Huber KM. Metabotropic receptor-dependent long-term depression persists in the absence of protein synthesis in the mouse model of fragile X syndrome. J Neurophysiol 95: 3291-3295, 2006.
40. Oliet SH, Malenka RC, Nicoll RA. Two distinct forms of long-term depression coexist in CA1 hippocampal pyramidal cells. Neuron 18: 969-982, 1997.
41. Piomelli D. The molecular logic of endocannabinoid signalling. Nat Rev Neurosci 4: 873-884, 2003.
42. Reibaud M, Obinu MC, Ledent C, Parmentier M, Bohme GA, Imperato A. Enhancement of memory in cannabinoid CB1 receptor knock-out mice. Eur J Pharmacol 379: R1-2, 1999.
43. Rhee MH, Bayewitch M, Avidor-Reiss T, Levy R, Vogel Z. Cannabinoid receptor activation differentially regulates the various adenylyl cyclase isozymes. J Neurochem 71: 1525-1534, 1998.
44. Robbe D, Kopf M, Remaury A, Bockaert J, Manzoni OJ. Endogenous cannabinoids mediate long-term synaptic depression in the nucleus accumbens. Proc Natl Acad Sci USA 99: 8384-8388, 2002.
45. Roloff AM, Thayer SA. Modulation of excitatory synaptic transmission by {Delta}9-tetrahydrocannabinol switches from agonist to antagonist depending on firing rate. Mol Pharmacol 75: 892-900, 2009.
46. Safo PK, Regehr WG. Endocannabinoids control the induction of cerebellar LTD. Neuron 48: 647-659, 2005.
47. Sjostrom PJ, Turrigiano GG, Nelson SB. Endocannabinoid-dependent neocortical layer-5 LTD in the absence of postsynaptic spiking. J Neurophysiol 92: 3338-3343, 2004.
48. Sjostrom PJ, Turrigiano GG, Nelson SB. Neocortical LTD via coincident activation of presynaptic NMDA and cannabinoid receptors. Neuron 39: 641-654, 2003.
49. Stella N, Schweitzer P, Piomelli D. A second endogenous cannabinoid that modulates long-term potentiation. Nature 388: 773-778, 1997.
50. Straiker A, Mackie K. Depolarization-induced suppression of excitation in murine autaptic hippocampal neurones. J Physiol 569: 501-517, 2005.
51. Straiker A, Mackie K. Cannabinoids, electrophysiology, and retrograde messengers: challenges for the next 5 years. Aaps J 8: E272-276, 2006.
52. Straiker A, Mackie K. Metabotropic suppression of excitation in murine autaptic hippocampal neurons. J Physiol 578: 773-785, 2007.
53. Straiker AJ, Borden CR, Sullivan JM. G-Protein alpha subunit isoforms couple differentially to receptors that mediate presynaptic inhibition at rat hippocampal synapses. J Neurosci 22: 2460-2468, 2002.
54. Sullivan JM. Mechanisms of cannabinoid-receptor-mediated inhibition of synaptic transmission in cultured hippocampal pyramidal neurons. J Neurophysiol 82: 1286-1294, 1999.
55. Thiels E, Kanterewicz BI, Norman ED, Trzaskos JM, Klann E. Long-term depression in the adult hippocampus in vivo involves activation of extracellular signal-regulated kinase and phosphorylation of Elk-1. J Neurosci 22: 2054-2062, 2002.
56. Wilson RI, Nicoll RA. Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses. Nature 410: 588-592, 2001.
57. Yasuda H, Huang Y, Tsumoto T. Regulation of excitability and plasticity by endocannabinoids and PKA in developing hippocampus. Proc Natl Acad Sci USA 105: 3106-3111, 2008.
58. Yin HH, Davis MI, Ronesi JA, Lovinger DM. The role of protein synthesis in striatal long-term depression. J Neurosci 26: 11811-11820, 2006.
59. Zhu PJ, Lovinger DM. Persistent synaptic activity produces long-lasting enhancement of endocannabinoid modulation and alters long-term synaptic plasticity. J Neurophysiol 97: 4386-4389, 2007.